- Report
- October 2024
- 159 Pages
Global
From €3908EUR$4,000USD£3,263GBP
- Report
- June 2024
Global
From €7328EUR$7,500USD£6,118GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Report
- February 2024
- 75 Pages
Europe
From €2882EUR$2,950USD£2,406GBP
- Report
- February 2024
- 209 Pages
Europe
From €2838EUR$2,905USD£2,370GBP
€4055EUR$4,150USD£3,385GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3385EUR$3,465USD£2,826GBP
€4836EUR$4,950USD£4,038GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3907EUR$3,999USD£3,262GBP
- Report
- June 2024
- 140 Pages
Europe
From €3907EUR$3,999USD£3,262GBP
- Report
- June 2024
- 120 Pages
North America
From €3907EUR$3,999USD£3,262GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3907EUR$3,999USD£3,262GBP
- Report
- December 2020
- 120 Pages
Global
From €1954EUR$2,000USD£1,631GBP
- Report
- July 2023
- 230 Pages
Global
From €2394EUR$2,450USD£1,998GBP
- Report
- September 2023
- 100 Pages
Global
From €5813EUR$5,950USD£4,853GBP
- Newsletter
- November 2024
- 14 Pages
United Kingdom
- Newsletter
- November 2024
- 14 Pages
United States
- Report
- July 2021
- 50 Pages
China
From €2540EUR$2,600USD£2,121GBP
- Report
- June 2021
- 50 Pages
China
From €2540EUR$2,600USD£2,121GBP
- Report
- April 2021
- 50 Pages
China
From €2540EUR$2,600USD£2,121GBP
- Report
- September 2022
- 157 Pages
North America
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
The Colon Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy.
Chemotherapy drugs are used to kill cancer cells and stop them from growing. Targeted therapy drugs are designed to target specific cancer cells and block their growth. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer cells.
Some of the major companies in the Colon Cancer Drugs market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and marketing of drugs used to treat colon cancer. Show Less Read more